Contraception
Volume 82, Issue 4 , Pages 358-365, October 2010

Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles

  • Thomas Rabe

      Affiliations

    • University Women's Hospital, Voß-Str. 9, D-69115 Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 6221 567913; fax: +49 6221 560713.
    • ,
  • Elena Hartschuh

      Affiliations

    • Neuenheimer Landstr. 60, D-69120 Heidelberg, Germany
    • ,
  • Torsten Wahlstrom

      Affiliations

    • Laboratory of Pathology, Eira Hospital, Tehtaan Katu 28, SF-00150 Helsinki, Finland
    • ,
  • Kornelia Höschen

      Affiliations

    • Grunenthal GmbH, D-52099 Aachen, Germany
    • ,
  • Simone König

      Affiliations

    • Grunenthal GmbH, D-52099 Aachen, Germany

Received 18 September 2009; received in revised form 13 April 2010; accepted 14 April 2010. published online 12 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0010-7824(10)00150-2

doi:10.1016/j.contraception.2010.04.013

Contraception
Volume 82, Issue 4 , Pages 358-365, October 2010

Article Tools

* Image Usage & Resolution